Zhang, Yanxiao
Amaral, Maria Luisa
Zhu, Chenxu
Grieco, Steven Francis
Hou, Xiaomeng
Lin, Lin
Buchanan, Justin
Tong, Liqi
Preissl, Sebastian http://orcid.org/0000-0001-8971-5616
Xu, Xiangmin
Ren, Bing
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R01AG067153, R01AG066018, K99CA252020, T32GM008806-18, K99HG011483)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 24 March 2022
Accepted: 21 August 2022
First Online: 7 October 2022
Competing interests
: B.R. is a shareholder and consultant of Arima Genomics, Inc., and a co-founder of Epigenome Technologies, Inc.